Page last updated: 2024-10-23

bisbenzimidazole and Lymphoma

bisbenzimidazole has been researched along with Lymphoma in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saiko, P1
Bauer, W1
Horvath, Z1
Hoechtl, T1
Grusch, M1
Illmer, C1
Madlener, S1
Krupitza, G1
Mader, RM1
Schott, H1
Fritzer-Szekeres, M1
Szekeres, T1
Arnold, B1
Battye, FL1
Miller, JF1

Other Studies

2 other studies available for bisbenzimidazole and Lymphoma

ArticleYear
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; C

2004
An improved method for selecting T-cell hybridomas by the fluorescence-activated cell sorter.
    Journal of immunological methods, 1979, Volume: 29, Issue:4

    Topics: Animals; Antigens, Surface; Bisbenzimidazole; Cell Line; Cell Separation; DNA; Histocytochemistry; H

1979